427 related articles for article (PubMed ID: 31636069)
1. A Prospective Cohort Study of Durations of
Kang CK; Song KH; Kim SE; Kim ES; Park WB; Park KH; Chun SH; Lee S; Cho CR; Kang SJ; Oh MD; Kim YS; Lee SH; Kwak YG; Jang HC; Kim CJ; Kim YK; Bang JH; Kiem S; Kwon KT; Jung Y; Kang YM; Jung SI; Kim HB;
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31636069
[TBL] [Abstract][Full Text] [Related]
2. Gender affects prognosis of methicillin-resistant Staphylococcus aureus bacteremia differently depending on the severity of underlying disease.
Kang CK; Kwak YG; Park Y; Song KH; Kim ES; Jung SI; Park KH; Park WB; Kim NJ; Kim YK; Jang HC; Lee S; Jeon JH; Kwon KT; Kim CJ; Kim YS; Kim HB;
Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1119-1123. PubMed ID: 29667110
[TBL] [Abstract][Full Text] [Related]
3. Feedback to clinicians on preventable factors can reduce hospital onset Staphylococcus aureus bacteraemia rates.
Kok J; O'Sullivan MV; Gilbert GL
J Hosp Infect; 2011 Oct; 79(2):108-14. PubMed ID: 21741724
[TBL] [Abstract][Full Text] [Related]
4. Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study.
Chong YP; Moon SM; Bang KM; Park HJ; Park SY; Kim MN; Park KH; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS
Antimicrob Agents Chemother; 2013 Mar; 57(3):1150-6. PubMed ID: 23254436
[TBL] [Abstract][Full Text] [Related]
5. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.
Abbas M; Rossel A; de Kraker MEA; von Dach E; Marti C; Emonet S; Harbarth S; Kaiser L; Uçkay I
Clin Microbiol Infect; 2020 May; 26(5):626-631. PubMed ID: 31357013
[TBL] [Abstract][Full Text] [Related]
6. The Utility of Risk Factors to Define Complicated Staphylococcus aureus Bacteremia in a Setting With Low Methicillin-Resistant S. aureus Prevalence.
van der Vaart TW; Prins JM; Goorhuis A; Lemkes BA; Sigaloff KCE; Spoorenberg V; Stijnis C; Bonten MJM; van der Meer JTM
Clin Infect Dis; 2024 Apr; 78(4):846-854. PubMed ID: 38157401
[TBL] [Abstract][Full Text] [Related]
7. Factors for mortality in patients with persistent Staphylococcus aureus bacteremia: The importance of treatment response rather than bacteremia duration.
Kim SH; Jeon M; Jang S; Mun SJ
J Microbiol Immunol Infect; 2023 Oct; 56(5):1007-1015. PubMed ID: 37580183
[TBL] [Abstract][Full Text] [Related]
8. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.
Kim SH; Park WB; Lee KD; Kang CI; Kim HB; Oh MD; Kim EC; Choe KW
Clin Infect Dis; 2003 Sep; 37(6):794-9. PubMed ID: 12955640
[TBL] [Abstract][Full Text] [Related]
9. Association of methicillin resistance with mortality of hospital-acquired
Aratani T; Tsukamoto H; Higashi T; Kodawara T; Yano R; Hida Y; Iwasaki H; Goto N
J Int Med Res; 2021 Nov; 49(11):3000605211058872. PubMed ID: 34826374
[TBL] [Abstract][Full Text] [Related]
10. Persistent Staphylococcus aureus bacteremia: a prospective analysis of risk factors, outcomes, and microbiologic and genotypic characteristics of isolates.
Chong YP; Park SJ; Kim HS; Kim ES; Kim MN; Park KH; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS
Medicine (Baltimore); 2013 Mar; 92(2):98-108. PubMed ID: 23429353
[TBL] [Abstract][Full Text] [Related]
11. Clinical and microbiological factors associated with early patient mortality from methicillin-resistant Staphylococcus aureus bacteremia.
Kim T; Chong YP; Park KH; Bang KM; Park SJ; Kim SH; Jeong JY; Lee SO; Choi SH; Woo JH; Kim YS
Korean J Intern Med; 2019 Jan; 34(1):184-194. PubMed ID: 28859468
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus.
Falcón R; Mateo E; Oltra R; Giménez E; Albert E; Torres I; Navarro D
Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):903-912. PubMed ID: 30729396
[TBL] [Abstract][Full Text] [Related]
13. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2018.
Coombs GW; Daley DA; Mowlaboccus S; Lee YT; Pang S;
Commun Dis Intell (2018); 2020 Mar; 44():. PubMed ID: 32178604
[TBL] [Abstract][Full Text] [Related]
14. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries.
Ammerlaan H; Seifert H; Harbarth S; Brun-Buisson C; Torres A; Antonelli M; Kluytmans J; Bonten M;
Clin Infect Dis; 2009 Oct; 49(7):997-1005. PubMed ID: 19719417
[TBL] [Abstract][Full Text] [Related]
15. A Risk-Scoring System for Predicting Methicillin Resistance in Community-Onset Staphylococcus aureus Bacteremia in Korea.
Suh HJ; Park WB; Jung SI; Song KH; Kwak YG; Kim KH; Hwang JH; Yun NR; Jang HC; Kim YK; Kim NH; Park KH; Kang SJ; Lee S; Kim ES; Kim HB
Microb Drug Resist; 2018 Jun; 24(5):556-562. PubMed ID: 29863981
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and hospital readmission associated with complications of Staphylococcus aureus bacteremia in pediatrics over a 25-year period.
Le J; Dam Q; Tran T; Nguyen A; Adler-Shohet FC; Kim S; Schmidt K; Lieberman JM; Bradley JS
Epidemiol Infect; 2017 Sep; 145(12):2631-2639. PubMed ID: 28748772
[TBL] [Abstract][Full Text] [Related]
17. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2017.
Coombs GW; Daley DA; Lee YT; Pang S
Commun Dis Intell (2018); 2019 Sep; 43():. PubMed ID: 31522665
[TBL] [Abstract][Full Text] [Related]
18. agr Dysfunction and persistent methicillin-resistant Staphylococcus aureus bacteremia in patients with removed eradicable foci.
Park SY; Chong YP; Park HJ; Park KH; Moon SM; Jeong JY; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS
Infection; 2013 Feb; 41(1):111-9. PubMed ID: 23065454
[TBL] [Abstract][Full Text] [Related]
19. Daptomycin Plus Oxacillin for Persistent Methicillin-Susceptible
Kufel WD; Zagoria Z; Blaine BE; Steele JM; Mahapatra R; Paolino KM; Thomas SJ
Ann Pharmacother; 2024 Apr; 58(4):360-365. PubMed ID: 37542415
[TBL] [Abstract][Full Text] [Related]
20. Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.
Khatib R; Johnson LB; Sharma M; Fakih MG; Ganga R; Riederer K
Scand J Infect Dis; 2009; 41(1):4-9. PubMed ID: 18821135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
